PMC:7205724 / 9910-10086 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"314","span":{"begin":112,"end":120},"obj":"Species"},{"id":"315","span":{"begin":136,"end":144},"obj":"Disease"}],"attributes":[{"id":"A314","pred":"tao:has_database_id","subj":"314","obj":"Tax:9606"},{"id":"A315","pred":"tao:has_database_id","subj":"315","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ibodies that act directly to neutralize viral infectivity.\n\n4.1 Serum therapy\n\n4.1.1 Convalescent plasma from patients recovered from COVID-19\n\n4.1.1.1 Hypothesis: Plasma fr"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T69","span":{"begin":65,"end":70},"obj":"Body_part"},{"id":"T70","span":{"begin":100,"end":106},"obj":"Body_part"},{"id":"T71","span":{"begin":167,"end":173},"obj":"Body_part"}],"attributes":[{"id":"A69","pred":"fma_id","subj":"T69","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A70","pred":"fma_id","subj":"T70","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A71","pred":"fma_id","subj":"T71","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"ibodies that act directly to neutralize viral infectivity.\n\n4.1 Serum therapy\n\n4.1.1 Convalescent plasma from patients recovered from COVID-19\n\n4.1.1.1 Hypothesis: Plasma fr"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T4","span":{"begin":65,"end":70},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"ibodies that act directly to neutralize viral infectivity.\n\n4.1 Serum therapy\n\n4.1.1 Convalescent plasma from patients recovered from COVID-19\n\n4.1.1.1 Hypothesis: Plasma fr"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T56","span":{"begin":136,"end":144},"obj":"Disease"}],"attributes":[{"id":"A56","pred":"mondo_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ibodies that act directly to neutralize viral infectivity.\n\n4.1 Serum therapy\n\n4.1.1 Convalescent plasma from patients recovered from COVID-19\n\n4.1.1.1 Hypothesis: Plasma fr"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T103","span":{"begin":100,"end":106},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T104","span":{"begin":167,"end":173},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"ibodies that act directly to neutralize viral infectivity.\n\n4.1 Serum therapy\n\n4.1.1 Convalescent plasma from patients recovered from COVID-19\n\n4.1.1.1 Hypothesis: Plasma fr"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T45","span":{"begin":46,"end":57},"obj":"http://purl.obolibrary.org/obo/IDO_0000464"}],"text":"ibodies that act directly to neutralize viral infectivity.\n\n4.1 Serum therapy\n\n4.1.1 Convalescent plasma from patients recovered from COVID-19\n\n4.1.1.1 Hypothesis: Plasma fr"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T73","span":{"begin":136,"end":144},"obj":"Species"}],"attributes":[{"id":"A73","pred":"ncbi_taxonomy_id","subj":"T73","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"ibodies that act directly to neutralize viral infectivity.\n\n4.1 Serum therapy\n\n4.1.1 Convalescent plasma from patients recovered from COVID-19\n\n4.1.1.1 Hypothesis: Plasma fr"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T83","span":{"begin":60,"end":78},"obj":"Sentence"},{"id":"T84","span":{"begin":80,"end":144},"obj":"Sentence"},{"id":"T85","span":{"begin":146,"end":166},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ibodies that act directly to neutralize viral infectivity.\n\n4.1 Serum therapy\n\n4.1.1 Convalescent plasma from patients recovered from COVID-19\n\n4.1.1.1 Hypothesis: Plasma fr"}

{"project":"LitCovid-sample-PD-UBERON","denotations":[{"id":"T4","span":{"begin":65,"end":70},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"ibodies that act directly to neutralize viral infectivity.\n\n4.1 Serum therapy\n\n4.1.1 Convalescent plasma from patients recovered from COVID-19\n\n4.1.1.1 Hypothesis: Plasma fr"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"314","span":{"begin":112,"end":120},"obj":"Species"},{"id":"315","span":{"begin":136,"end":144},"obj":"Disease"}],"attributes":[{"id":"A314","pred":"pubann:denotes","subj":"314","obj":"Tax:9606"},{"id":"A315","pred":"pubann:denotes","subj":"315","obj":"MESH:C000657245"}],"text":"ibodies that act directly to neutralize viral infectivity.\n\n4.1 Serum therapy\n\n4.1.1 Convalescent plasma from patients recovered from COVID-19\n\n4.1.1.1 Hypothesis: Plasma fr"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T1685","span":{"begin":8,"end":12},"obj":"WDT"},{"id":"T1686","span":{"begin":13,"end":16},"obj":"VBP"},{"id":"T1687","span":{"begin":17,"end":25},"obj":"RB"},{"id":"T1688","span":{"begin":26,"end":28},"obj":"TO"},{"id":"T1689","span":{"begin":29,"end":39},"obj":"VB"},{"id":"T1690","span":{"begin":40,"end":45},"obj":"JJ"},{"id":"T1691","span":{"begin":46,"end":57},"obj":"NN"},{"id":"T1692","span":{"begin":60,"end":63},"obj":"CD"},{"id":"T1693","span":{"begin":65,"end":70},"obj":"NN"},{"id":"T1694","span":{"begin":71,"end":78},"obj":"NN"},{"id":"T34096","span":{"begin":80,"end":85},"obj":"CD"},{"id":"T81207","span":{"begin":87,"end":99},"obj":"JJ"},{"id":"T7654","span":{"begin":100,"end":106},"obj":"NN"},{"id":"T71050","span":{"begin":107,"end":111},"obj":"IN"},{"id":"T25890","span":{"begin":112,"end":120},"obj":"NNS"},{"id":"T44174","span":{"begin":121,"end":130},"obj":"VBN"},{"id":"T26910","span":{"begin":131,"end":135},"obj":"IN"},{"id":"T41378","span":{"begin":136,"end":144},"obj":"NN"},{"id":"T88463","span":{"begin":146,"end":153},"obj":"CD"},{"id":"T5371","span":{"begin":155,"end":165},"obj":"NN"},{"id":"T65084","span":{"begin":165,"end":166},"obj":"-COLON-"},{"id":"T11805","span":{"begin":167,"end":173},"obj":"NN"}],"relations":[{"id":"R1680","pred":"arg1Of","subj":"T1686","obj":"T1687"},{"id":"R1681","pred":"arg1Of","subj":"T1689","obj":"T1688"},{"id":"R1682","pred":"modOf","subj":"T1686","obj":"T1688"},{"id":"R1684","pred":"arg2Of","subj":"T1691","obj":"T1689"},{"id":"R1685","pred":"arg1Of","subj":"T1691","obj":"T1690"},{"id":"R1686","pred":"arg1Of","subj":"T1694","obj":"T1692"},{"id":"R1687","pred":"arg1Of","subj":"T1694","obj":"T1693"},{"id":"R9700","pred":"arg1Of","subj":"T7654","obj":"T34096"},{"id":"R55934","pred":"arg1Of","subj":"T7654","obj":"T81207"},{"id":"R34567","pred":"arg1Of","subj":"T7654","obj":"T71050"},{"id":"R8614","pred":"arg2Of","subj":"T25890","obj":"T71050"},{"id":"R19161","pred":"arg2Of","subj":"T25890","obj":"T44174"},{"id":"R3402","pred":"arg1Of","subj":"T44174","obj":"T26910"},{"id":"R78843","pred":"arg2Of","subj":"T41378","obj":"T26910"},{"id":"R18397","pred":"arg1Of","subj":"T5371","obj":"T88463"},{"id":"R76601","pred":"arg1Of","subj":"T5371","obj":"T65084"}],"text":"ibodies that act directly to neutralize viral infectivity.\n\n4.1 Serum therapy\n\n4.1.1 Convalescent plasma from patients recovered from COVID-19\n\n4.1.1.1 Hypothesis: Plasma fr"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T69","span":{"begin":65,"end":70},"obj":"Body_part"},{"id":"T70","span":{"begin":100,"end":106},"obj":"Body_part"},{"id":"T71","span":{"begin":167,"end":173},"obj":"Body_part"}],"attributes":[{"id":"A69","pred":"fma_id","subj":"T69","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A70","pred":"fma_id","subj":"T70","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A71","pred":"fma_id","subj":"T71","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"ibodies that act directly to neutralize viral infectivity.\n\n4.1 Serum therapy\n\n4.1.1 Convalescent plasma from patients recovered from COVID-19\n\n4.1.1.1 Hypothesis: Plasma fr"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T55","span":{"begin":136,"end":144},"obj":"Disease"}],"attributes":[{"id":"A55","pred":"mondo_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ibodies that act directly to neutralize viral infectivity.\n\n4.1 Serum therapy\n\n4.1.1 Convalescent plasma from patients recovered from COVID-19\n\n4.1.1.1 Hypothesis: Plasma fr"}

{"project":"LitCovid-sentences","denotations":[{"id":"T83","span":{"begin":60,"end":78},"obj":"Sentence"},{"id":"T84","span":{"begin":80,"end":144},"obj":"Sentence"},{"id":"T85","span":{"begin":146,"end":166},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ibodies that act directly to neutralize viral infectivity.\n\n4.1 Serum therapy\n\n4.1.1 Convalescent plasma from patients recovered from COVID-19\n\n4.1.1.1 Hypothesis: Plasma fr"}